Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders

. 2022 Jan 01 ; 91 (1) : 102-117. [epub] 20210323

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/pmid34099189

Grantová podpora
R01 CA229618 NCI NIH HHS - United States
R01 MH104964 NIMH NIH HHS - United States
4584 Cancer Research UK - United Kingdom
U54 MH118919 NIMH NIH HHS - United States
R01 MH123451 NIMH NIH HHS - United States
G0901310 Medical Research Council - United Kingdom
R01 MH092380 NIMH NIH HHS - United States

Odkazy

PubMed 34099189
PubMed Central PMC8458480
DOI 10.1016/j.biopsych.2021.02.972
PII: S0006-3223(21)01139-2
Knihovny.cz E-zdroje

BACKGROUND: Sex differences in incidence and/or presentation of schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for shared genetic risk and sex differences in brain abnormalities across disorders suggest possible shared sex-dependent genetic risk. METHODS: We conducted the largest to date genome-wide genotype-by-sex (G×S) interaction of risk for these disorders using 85,735 cases (33,403 SCZ, 19,924 BIP, and 32,408 MDD) and 109,946 controls from the PGC (Psychiatric Genomics Consortium) and iPSYCH. RESULTS: Across disorders, genome-wide significant single nucleotide polymorphism-by-sex interaction was detected for a locus encompassing NKAIN2 (rs117780815, p = 3.2 × 10-8), which interacts with sodium/potassium-transporting ATPase (adenosine triphosphatase) enzymes, implicating neuronal excitability. Three additional loci showed evidence (p < 1 × 10-6) for cross-disorder G×S interaction (rs7302529, p = 1.6 × 10-7; rs73033497, p = 8.8 × 10-7; rs7914279, p = 6.4 × 10-7), implicating various functions. Gene-based analyses identified G×S interaction across disorders (p = 8.97 × 10-7) with transcriptional inhibitor SLTM. Most significant in SCZ was a MOCOS gene locus (rs11665282, p = 1.5 × 10-7), implicating vascular endothelial cells. Secondary analysis of the PGC-SCZ dataset detected an interaction (rs13265509, p = 1.1 × 10-7) in a locus containing IDO2, a kynurenine pathway enzyme with immunoregulatory functions implicated in SCZ, BIP, and MDD. Pathway enrichment analysis detected significant G×S interaction of genes regulating vascular endothelial growth factor receptor signaling in MDD (false discovery rate-corrected p < .05). CONCLUSIONS: In the largest genome-wide G×S analysis of mood and psychotic disorders to date, there was substantial genetic overlap between the sexes. However, significant sex-dependent effects were enriched for genes related to neuronal development and immune and vascular functions across and within SCZ, BIP, and MDD at the variant, gene, and pathway levels.

Biometric Psychiatric Genetics Research Unit Alexandru Obregia Clinical Psychiatric Hospital Bucharest Romania

Broad Institute of MIT and Harvard Cambridge Massachusetts; Institute of Genomics University of Tartu Tartu Estonia

Cancer Epidemiology and Prevention M Sklodowska Curie National Research Institute of Oncology Warsaw Poland

Center for Psychopharmacology Diakonhjemmet Hospital Oslo Norway; Department of Pharmaceutical Biosciences School of Pharmacy University of Oslo Oslo Norway

Center for Statistical Genetics and Department of Biostatistics University of Michigan Ann Arbor Michigan

Centre for Addiction and Mental Health Toronto Ontario Canada

Centre for Affective Disorders Institute of Psychiatry Psychology and Neuroscience London United Kingdom; Department of Psychiatry and Addiction Medicine Assistance Publique Hôpitaux de Paris Paris France; UMR S1144 Team 1 Biomarkers of relapse and therapeutic response in addiction and mood disorders INSERM Paris France; Psychiatry Université Paris Diderot Paris France

Centre for Human Genetics University of Marburg Marburg Germany; Institute of Human Genetics University of Bonn School of Medicine and University Hospital Bonn Bonn Germany

Centre for Integrative Sequencing Copenhagen Denmark

Child and Adolescent Psychiatry Erasmus Medical Center Rotterdam the Netherlands

Department of Biological Psychology Netherlands Twin Register Vrije Universiteit Amsterdam Amsterdam the Netherlands; Amsterdam Public Health Research Institute Amsterdam UMC Amsterdam the Netherlands

Department of Biomedicine Aarhus University Aarhus Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research Aarhus Denmark

Department of Biomedicine Aarhus University Aarhus Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research Copenhagen Denmark; Center for Genome Analysis and Personalized Medicine Aarhus Denmark

Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark; Institute of Biological Psychiatry Mental Health Center Sct Hans Mental Health Services Copenhagen Roskilde Denmark

Department of Clinical Neuroscience Max Planck Institute of Experimental Medicine Göttingen Germany

Department of Clinical Neuroscience Psychiatry Section Karolinska Institutet Stockholm Sweden; Norwegian Centre for Mental Disorders Research KG Jebsen Centre for Psychosis Research Institute of Clinical Medicine University of Oslo Oslo Norway

Department of Clinical Sciences Psychiatry Umeå University Medical Faculty Umeå Sweden

Department of Environmental Epidemiology Nofer Institute of Occupational Medicine Lodz Poland

Department of Genetic Epidemiology in Psychiatry Central Institute of Mental Health Medical Faculty Mannheim Heidelberg University Mannheim Germany

Department of Health Sciences Research Mayo Clinic Rochester Minnesota

Department of Medical and Molecular Genetics King's College London London United Kingdom

Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden; Institute of Neuroscience and Physiology the Sahlgrenska Academy at Gothenburg University Gothenburg Sweden

Department of Medical Genetics Oslo University Hospital Oslo Norway; NORMENT Centre Department of Clinical Science University of Bergen Bergen Norway

Department of Mental Health Norwegian University of Science and Technology NTNU Trondheim Norway; Department of Psychiatry St Olavs' University Hospital Trondheim Norway

Department of Psychiatry and Addiction Medicine Assistance Publique Hôpitaux de Paris Paris France; UMR S1144 Team 1 Biomarkers of relapse and therapeutic response in addiction and mood disorders INSERM Paris France; Psychiatry Université Paris Diderot Paris France; Paris Bipolar and TRD Expert Centres FondaMental Foundation Paris France

Department of Psychiatry and Behavioral Neuroscience University of Chicago Chicago Illinois; Department of Psychiatry and Behavioral Sciences North Shore University Health System Evanston Illinois

Department of Psychiatry and Behavioral Sciences SUNY Upstate Medical University Syracuse New York; Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore Maryland; Institute of Psychiatric Phenomics and Genomics University Hospital LMU Munich Munich Germany; Department of Genetic Epidemiology in Psychiatry Central Institute of Mental Health Medical Faculty Mannheim Heidelberg University Mannheim Germany; Department of Psychiatry and Psychotherapy University Medical Center Göttingen Göttingen Germany

Department of Psychiatry and Neuropsychology School for Mental Health and Neuroscience Faculty of Health Medicine and Life Sciences Maastricht University Maastricht the Netherlands; Psychiatric and Neurodevelopmental Genetics Unit Department of Psychiatry and Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts; Department of Psychiatry Harvard Medical School Boston Massachusetts; Stanley Center for Psychiatric Research Broad Institute of MIT and Harvard Cambridge Massachusetts

Department of Psychiatry and Psychology Mayo Clinic Rochester Minnesota

Department of Psychiatry and Psychotherapy University Medicine Greifswald Greifswald Germany

Department of Psychiatry Columbia University College of Physicians and Surgeons New York New York; Division of Translational Epidemiology New York State Psychiatric Institute New York New York

Department of Psychiatry Dalhousie University Halifax Nova Scotia Canada

Department of Psychiatry Dalhousie University Halifax Nova Scotia Canada; National Institute of Mental Health Klecany Czech Republic

Department of Psychiatry Fujita Health University School of Medicine Toyoake Aichi Japan

Department of Psychiatry Icahn School of Medicine at Mount Sinai New York New York; Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York New York; Social Genetic and Developmental Psychiatry Centre King's College London London United Kingdom

Department of Psychiatry Laboratory of Psychiatric Genetics Poznan University of Medical Sciences Poznan Poland

Department of Psychiatry Lausanne University Hospital and University of Lausanne Lausanne Switzerland

Department of Psychiatry Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong SAR China; State Key Laboratory for Brain and Cognitive Sciences Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong SAR China; Centre for Genomic Sciences The University of Hong Kong Hong Kong SAR China

Department of Psychiatry Melbourne Medical School University of Melbourne Melbourne Victoria Australia; Florey Institute for Neuroscience and Mental Health University of Melbourne Parkville Victoria Australia; Department of Psychiatry University of Münster Münster Germany

Department of Psychiatry Mood Disorders Program McGill University Health Center Montréal Québec Canada

Department of Psychiatry Psychosomatic Medicine and Psychotherapy University Hospital Frankfurt Frankfurt am Main Germany

Department of Psychiatry University of California San Diego La Jolla California

Department of Psychiatry University of Halle Halle Germany

Department of Psychiatry University of Halle Halle Germany; Department of Psychiatry University of Munich Munich Germany

Department of Psychiatry University of Iowa Iowa City Iowa

Department of Psychiatry Vrije Universiteit Medical Center and GGZ inGeest Amsterdam the Netherlands

Department of Translational Research in Psychiatry Max Planck Institute of Psychiatry Munich Germany; Max Planck Institute of Psychiatry Munich Germany

Departments of Genetics and Psychiatry University of North Carolina at Chapel Hill Chapel Hill North Carolina; Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

Departments of Human Genetics and Neuroscience Icahn School of Medicine at Mount Sinai New York New York; Department of Psychiatry Icahn School of Medicine at Mount Sinai New York New York; Friedman Brain Institute Icahn School of Medicine at Mount Sinai New York New York

Discipline of Psychiatry The University of Adelaide Adelaide South Austrlalia Australia

Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland

Division of Psychiatry University of Edinburgh Edinburgh United Kingdom

Division of Psychiatry University of Edinburgh Edinburgh United Kingdom; Centre for Cognitive Ageing and Cognitive Epidemiology University of Edinburgh Edinburgh United Kingdom

Faculté de Médecine Université Paris Est Créteil France; Department of Psychiatry and Addiction Medicine Assistance Publique Hôpitaux de Paris Paris France; Institut national de la santé et de la recherche médicale Paris France

Faculté de Médecine Université Paris Est Créteil France; INSERM U955 Psychiatrie Translationnelle Créteil France

Innovation Center on Sex Differences in Medicine Massachusetts General Hospital Boston Massachusetts; Department of Biomedical Sciences Colorado State University Fort Collins Colorado

Innovation Center on Sex Differences in Medicine Massachusetts General Hospital Boston Massachusetts; Department of Psychiatry and Vincent Department of Obstetrics Gynecology and Reproductive Biology Massachusetts General Hospital Boston Massachusetts; MGH MIT HMS Athinoula A Martinos Center for Biomedical Imaging Charlestown Massachusetts; Departments of Psychiatry and Medicine Harvard Medical School Boston Massachusetts

Institute for Genomic Health SUNY Downstate Medical Center College of Medicine Brooklyn New York; Department of Psychiatry and Zilkha Neurogenetics Institute Keck School of Medicine at University of Southern California Los Angeles California

Institute of Community Medicine University Medicine Greifswald Greifswald Germany

Institute of Human Genetics University of Bonn School of Medicine and University Hospital Bonn Bonn Germany

Institute of Human Genetics University of Bonn School of Medicine and University Hospital Bonn Bonn Germany; Department of Child and Adolescent Psychiatry Psychosomatics and Psychotherapy University Hospital Essen University of Duisburg Essen Duisburg Germany

Institute of Human Genetics University of Bonn School of Medicine and University Hospital Bonn Bonn Germany; Institute of Neuroscience and Medicine Research Centre Jülich Jülich Germany; Department of Biomedicine University of Basel Basel Switzerland; Institute of Medical Genetics and Pathology University Hospital Basel Basel Switzerland

Institute of Psychiatric Phenomics and Genomics Munich Germany

Institute of Psychiatric Phenomics and Genomics University Hospital LMU Munich Munich Germany

Institute of Psychiatry King's College London London United Kingdom

Interfaculty Institute for Genetics and Functional Genomics University Medicine Greifswald Greifswald Germany

ISGlobal Barcelona Spain

Kaiser Permanente Northern California San Francisco California

Lieber Institute for Brain Development Baltimore Maryland; Departments of Psychiatry Neurology Neuroscience and Institute of Genetic Medicine Johns Hopkins University School of Medicine Baltimore Maryland

Medical and Population Genetics Broad Institute of MIT and Harvard Cambridge Massachusetts; Department of Psychiatry Icahn School of Medicine at Mount Sinai New York New York; Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York New York

Mental Health Department University Regional Hospital Biomedical Research Institute of Málaga Málaga Spain

Mental Health Neuroscience Research Department Division of Psychiatry Faculty of Brain Sciences University College London London United Kingdom

Molecular Psychiatry Laboratory Division of Psychiatry University College London London United Kingdom

MRC Centre for Neuropsychiatric Genetics and Genomics Institute of Psychological Medicine and Clinical Neurosciences School of Medicine Cardiff University Cardiff United Kingdom

Neuropsychiatric Genetics Research Group Department of Psychiatry Trinity College Dublin Dublin Ireland

Neuroscience Research Australia Sydney New South Wales Australia; School of Medical Sciences University of New South Wales Sydney New South Wales Australia

NIHR Maudsley Biomedical Research Centre King's College London London United Kingdom

Norwegian Centre for Mental Disorders Research Institute of Clinical Medicine University of Oslo and Division of Mental Health and Addiction Oslo University Hospital Oslo Norway

Priority Centre for Translational Neuroscience and Mental Health University of Newcastle Newcastle New South Wales Australia

Psychiatric and Neurodevelopmental Genetics Unit Department of Psychiatry and Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts; Biogen Inc Cambridge Massachusetts

Psychiatric and Neurodevelopmental Genetics Unit Department of Psychiatry and Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts; Department of Psychiatry Harvard Medical School Boston Massachusetts; Stanley Center for Psychiatric Research Broad Institute of MIT and Harvard Cambridge Massachusetts

Psychiatric and Neurodevelopmental Genetics Unit Department of Psychiatry and Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts; Department of Psychiatry Harvard Medical School Boston Massachusetts; Stanley Center for Psychiatric Research Broad Institute of MIT and Harvard Cambridge Massachusetts; Concert Pharmaceuticals Inc Lexington Massachusetts

Psychiatric and Neurodevelopmental Genetics Unit Department of Psychiatry and Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts; Stanley Center for Psychiatric Research Broad Institute of MIT and Harvard Cambridge Massachusetts; Institute for Molecular Medicine Finland University of Helsinki Helsinki Finland

Psychiatry and Behavioral Sciences Stanford University Stanford California

Psychiatry and The Behavioral Sciences University of Southern California Los Angeles California

Queensland Brain Institute University of Queensland Brisbane Queensland Australia; Queensland Centre for Mental Health Research The Park Centre for Mental Health Wacol Queensland Australia

Queensland Brain Institute University of Queensland Brisbane Queensland Australia; Queensland Centre for Mental Health Research University of Queensland Brisbane Queensland Australia

Research Division and Department of General Psychiatry Institute of Mental Health Singapore Singapore; Duke National University of Singapore Graduate Medical School Singapore

Research Institute Lindner Center of HOPE Mason Ohio

Schizophrenia Research Institute Sydney New South Wales Australia; School of Biomedical Sciences and Pharmacy University of Newcastle Callaghan New South Wales Australia; Priority Centre for Translational Neuroscience and Mental Health University of Newcastle Newcastle New South Wales Australia

School of Biomedical Sciences and Pharmacy University of Newcastle Callaghan New South Wales Australia; Priority Centre for Translational Neuroscience and Mental Health University of Newcastle Newcastle New South Wales Australia; Schizophrenia Research Institute Sydney New South Wales Australia

School of Biomedical Sciences and Pharmacy University of Newcastle Callaghan New South Wales Australia; Schizophrenia Research Institute Sydney New South Wales Australia

School of Psychiatry University of New South Wales Sydney New South Wales Australia

School of Psychology and Counseling Queensland University of Technology Brisbane Queensland Australia

School of Psychology University of Queensland Brisbane Queensland Australia; Genetics and Computational Biology QIMR Berghofer Medical Research Institute Brisbane Queensland Australia

Stanley Center for Psychiatric Research Broad Institute of MIT and Harvard Cambridge Massachusetts; Broad Institute of MIT and Harvard Cambridge Massachusetts; Medical and Population Genetics Broad Institute of MIT and Harvard Cambridge Massachusetts; Institute of Genomics University of Tartu Tartu Estonia

Stanley Center for Psychiatric Research Broad Institute of MIT and Harvard Cambridge Massachusetts; Departments of Neurology and Genetics Yale School of Medicine New Haven Connecticut

The Feinstein Institute for Medical Research Manhasset New York; The Zucker School of Medicine at Hofstra Northwell Hempstead New York; The Zucker Hillside Hospital Glen Oaks New York

The Lundbeck Foundation Initiative for Integrative Psychiatric Research Copenhagen Denmark; Center for Neonatal Screening Department for Congenital Disorders Statens Serum Institut Copenhagen Denmark

The Lundbeck Foundation Initiative for Integrative Psychiatric Research Copenhagen Denmark; Copenhagen Mental Health Center Mental Health Services Capital Region of Denmark Copenhagen Copenhagen Denmark; Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

The Lundbeck Foundation Initiative for Integrative Psychiatric Research Copenhagen Denmark; Psychosis Research Unit Aarhus University Hospital Risskov Denmark

University Medical Center Utrecht Department of Psychiatry Rudolf Magnus Institute of Neuroscience Utrecht the Netherlands; Department of Human Genetics University of California Los Angeles California; David Geffen School of Medicine and Center for Neurobehavioral Genetics Semel Institute for Neuroscience and Human Behavior University of California Los Angeles California

University of Aberdeen Institute of Medical Sciences Aberdeen United Kingdom

University of Liverpool Liverpool United Kingdom; Department of Translational Research in Psychiatry Max Planck Institute of Psychiatry Munich Germany; Munich Cluster for Systems Neurology Munich Germany

Virginia Institute for Psychiatric and Behavioral Genetics Departments of Psychiatry and Human and Molecular Genetics Virginia Commonwealth University Richmond Virginia

Zobrazit více v PubMed

Salk RH, Hyde JS, Abramson LY (2017): Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychol Bull. 143:783–822. PubMed PMC

Jongsma HE, Turner C, Kirkbride JB, Jones PB (2019): International incidence of psychotic disorders, 2002-17: A systematic review and meta-analysis. Lancet Public Health. 4:e229–e244. PubMed PMC

Diflorio A, Jones I (2010): Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry. 22:437–452. PubMed

Erol A, Winham SJ, McElroy SL, Frye MA, Prieto ML, Cuellar-Barboza AB, et al. (2015): Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder. Bipolar Disord. 17:670–676. PubMed

Falkenburg J, Tracy DK (2014): Sex and schizophrenia: A review of gender differences. Psychosis. 6:61–69.

Leung A, Chue P (2000): Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl. 401:3–38. PubMed

Schuch JJ, Roest AM, Nolen WA, Penninx BW, de Jonge P (2014): Gender differences in major depressive disorder: Results from the Netherlands study of depression and anxiety. J Affect Disord. 156:156–163. PubMed

Mareckova K, Holsen L, Admon R, Whitfield-Gabrieli S, Seidman LJ, Buka SL, et al. (2017): Neural - hormonal responses to negative affective stimuli: Impact of dysphoric mood and sex. J Affect Disord. 222:88–97. PubMed PMC

Mareckova K, Holsen LM, Admon R, Makris N, Seidman L, Buka S, et al. (2016): Brain activity and connectivity in response to negative affective stimuli: Impact of dysphoric mood and sex across diagnoses. Hum Brain Mapp. 37:3733–3744. PubMed PMC

Polderman TJ, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, et al. (2015): Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet. 47:702–709. PubMed

Vink JM, Bartels M, van Beijsterveldt TC, van Dongen J, van Beek JH, Distel MA, et al. (2012): Sex differences in genetic architecture of complex phenotypes? PLoS One. 7:e47371. PubMed PMC

Stringer S, Polderman TJC, Posthuma D (2017): Majority of human traits do not show evidence for sex-specific genetic and environmental effects. Sci Rep. 7:8688. PubMed PMC

Weiss LA, Pan L, Abney M, Ober C (2006): The sex-specific genetic architecture of quantitative traits in humans. Nat Genet. 38:218–222. PubMed

Yang J, Bakshi A, Zhu Z, Hemani G, Vinkhuyzen AA, Nolte IM, et al. (2015): Genome-wide genetic homogeneity between sexes and populations for human height and body mass index. Hum Mol Genet. 24:7445–7449. PubMed

Goldstein JM, Faraone SV, Chen WJ, Tsuang MT (1995): Genetic heterogeneity may in part explain sex differences in the familial risk for schizophrenia. Biol Psychiatry. 38:808–813. PubMed

Goldstein JM, Cherkerzian S, Tsuang MT, Petryshen TL (2013): Sex differences in the genetic risk for schizophrenia: History of the evidence for sex-specific and sex-dependent effects. Am J Med Genet B Neuropsychiatr Genet. 162B:698–710. PubMed

Goldstein JM (1997): Sex differences in schizophrenia: Epidemiology, genetics and the brain. Int Rev Psychiatr. 9:399–408.

Goldstein JM, Seidman LJ, O'Brien LM, Horton NJ, Kennedy DN, Makris N, et al. (2002): Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry. 59:154–164. PubMed

Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. (2016): Schizophrenia risk from complex variation of complement component 4. Nature. 530:177–183. PubMed PMC

Kamitaki N, Sekar A, Handsaker RE, Rivera Hd, Tooley K, Morris DL, et al. (2020): Complement genes contribute sex-biased vulnerability in diverse disorders. Nature. 582:577–581. PubMed PMC

van Loo HM, Aggen SH, Gardner CO, Kendler KS (2018): Sex similarities and differences in risk factors for recurrence of major depression. Psychol Med. 48:1685–1693. PubMed

Bertschy G, Velten M, Weibel S (2016): Major depression: Does gender influence the risk of recurrence? A systematic review. Eur J Psychiat. 30:7–27.

Smith DJ, Nicholl BI, Cullen B, Martin D, Ul-Haq Z, Evans J, et al. (2013): Prevalence and characteristics of probable major depression and bipolar disorder within UK biobank: Cross-sectional study of 172,751 participants. PLoS One. 8:e75362. PubMed PMC

Duncan LE, Ratanatharathorn A, Aiello AE, Almli LM, Amstadter AB, Ashley-Koch AE, et al. (2018): Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability. Mol Psychiatry. 23:666–673. PubMed PMC

Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen CY, Choi KW, et al. (2019): International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nat Commun. 10:4558. PubMed PMC

Mitra I, Tsang K, Ladd-Acosta C, Croen LA, Aldinger KA, Hendren RL, et al. (2016): Pleiotropic mechanisms indicated for sex differences in autism. PLoS Genet. 12:e1006425. PubMed PMC

Khramtsova EA, Heldman R, Derks EM, Yu D, Tourette Syndrome/Obsessive-Compulsive Disorder Working Group of the Psychiatric Genomics C, Davis LK, et al. (2018): Sex differences in the genetic architecture of obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 180:351–364. PubMed PMC

Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, et al. (2016): Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet. 48:1031–1036. PubMed PMC

Walters R, Abbott L, Bryant S, Churchhouse C, Palmer D, Neale B (2018): Heritability of >2,000 traits and disorders in the UK Biobank. http://wwwnealelabis/uk-biobank/.

Hübel C, Gaspar HA, Coleman JRI, Finucane H, Purves KL, Hanscombe KB, et al. (2018): Genomics of body fat percentage may contribute to sex bias in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet. 180:428–438. PubMed PMC

Trzaskowski M, Mehta D, Peyrot WJ, Hawkes D, Davies D, Howard DM, et al. (2019): Quantifying between-cohort and between-sex genetic heterogeneity in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet. 180:439–447. PubMed PMC

Martin J, Walters RK, Demontis D, Mattheisen M, Lee SH, Robinson E, et al. (2018): A genetic investigation of sex bias in the prevalence of attention-deficit/hyperactivity disorder. Biol Psychiatry. 83:1044–1053. PubMed PMC

Rich-Edwards JW, Kaiser UB, Chen GL, Manson JE, Goldstein JM (2018): Sex and gender differences research design for basic, clinical, and population studies: Essentials for investigators. Endocr Rev. 39:424–439. PubMed PMC

Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, et al. (2013): A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 18:497–511. PubMed PMC

Psychiatric Genomics Consortium Schizophrenia Working Group (2014): Biological insights from 108 schizophrenia-associated genetic loci. Nature. 511:421–427. PubMed PMC

Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011): Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 43:977–983. PubMed PMC

Pedersen CB, Bybjerg-Grauholm J, Pedersen MG, Grove J, Agerbo E, Baekvad-Hansen M, et al. (2018): The iPSYCH2012 case-cohort sample: New directions for unravelling genetic and environmental architectures of severe mental disorders. Mol Psychiatry. 23:6–14. PubMed PMC

Lam M, Awasthi S, Watson HJ, Goldstein J, Panagiotaropoulou G, Trubetskoy V, et al. (2020): RICOPILI: Rapid Imputation for COnsortias PIpeLIne. Bioinformatics. 36:930–933. PubMed PMC

Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ (2015): Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience. 4:7. PubMed PMC

Willer CJ, Li Y, Abecasis GR (2010): METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 26:2190–2191. PubMed PMC

Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics Consortium, et al. (2015): LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 47:291–295. PubMed PMC

Zheng J, Erzurumluoglu AM, Elsworth BL, Kemp JP, Howe L, Haycock PC, et al. (2017): LD Hub: A centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics. 33:272–279. PubMed PMC

Keller MC (2014): Gene x environment interaction studies have not properly controlled for potential confounders: The problem and the (simple) solution. Biol Psychiatry. 75:18–24. PubMed PMC

Bhattacharjee S, Rajaraman P, Jacobs KB, Wheeler WA, Melin BS, Hartge P, et al. (2012): A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. Am J Hum Genet. 90:821–835. PubMed PMC

Benner C, Spencer CC, Havulinna AS, Salomaa V, Ripatti S, Pirinen M (2016): FINEMAP: Efficient variable selection using summary data from genome-wide association studies. Bioinformatics. 32:1493–1501. PubMed PMC

Hormozdiari F, Kostem E, Kang EY, Pasaniuc B, Eskin E (2014): Identifying causal variants at loci with multiple signals of association. Genetics. 198:497–508. PubMed PMC

de Leeuw CA, Mooij JM, Heskes T, Posthuma D (2015): MAGMA: Generalized gene-set analysis of GWAS data. PLoS computational biology. 11:e1004219. PubMed PMC

Network & Pathway Analysis Subgroup of Psychiatric Genomics Consortium (2015): Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci. 18:199–209. PubMed PMC

Pardinas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. (2018): Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 50:381–389. PubMed PMC

Gorokhova S, Bibert S, Geering K, Heintz N (2007): A novel family of transmembrane proteins interacting with beta subunits of the Na,K-ATPase. Hum Mol Genet. 16:2394–2410. PubMed

Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, et al. (2018): Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 9:2098. PubMed PMC

Aberg KA, Liu Y, Bukszar J, McClay JL, Khachane AN, Andreassen OA, et al. (2013): A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry. 70:573–581. PubMed PMC

Edwards AC, Bigdeli TB, Docherty AR, Bacanu S, Lee D, de Candia TR, et al. (2016): Meta-analysis of positive and negative symptoms reveals schizophrenia modifier genes. Schizophr Bull. 42:279–287. PubMed PMC

Peltola MA, Kuja-Panula J, Lauri SE, Taira T, Rauvala H (2011): AMIGO is an auxiliary subunit of the Kv2.1 potassium channel. EMBO Rep. 12:1293–1299. PubMed PMC

Bishop HI, Cobb MM, Kirmiz M, Parajuli LK, Mandikian D, Philp AM, et al. (2018): Kv2 ion channels determine the expression and localization of the associated AMIGO-1 cell adhesion molecule in adult brain neurons. Front Mol Neurosci. 11:1. PubMed PMC

Bem J, Brozko N, Chakraborty C, Lipiec MA, Kozinski K, Nagalski A, et al. (2019): Wnt/beta-catenin signaling in brain development and mental disorders: Keeping TCF7L2 in mind. FEBS Lett. 593:1654–1674. PubMed PMC

Hennig KM, Fass DM, Zhao WN, Sheridan SD, Fu T, Erdin S, et al. (2017): WNT/beta-Catenin pathway and epigenetic mechanisms regulate the Pitt-Hopkins syndrome and schizophrenia risk gene TCF4. Mol Neuropsychiatry. 3:53–71. PubMed PMC

Hoseth EZ, Krull F, Dieset I, Morch RH, Hope S, Gardsjord ES, et al. (2018): Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder. Transl Psychiatry. 8:55. PubMed PMC

Yu Z, Lin D, Zhong Y, Luo B, Liu S, Fei E, et al. (2019): Transmembrane protein 108 involves in adult neurogenesis in the hippocampal dentate gyrus. Cell Biosci. 9:9. PubMed PMC

He CW, Liao CP, Pan CL (2018): Wnt signalling in the development of axon, dendrites and synapses. Open Biol. 8:180116. PubMed PMC

O’Brien HE, Hannon E, Jeffries AR, Davies W, Hill MJ, Anney RJ, et al. (2018): Sex differences in gene expression in the human fetal brain. bioRxiv. doi: 10.1101/483636. DOI

McClellan KM, Stratton MS, Tobet SA (2010): Roles for gamma-aminobutyric acid in the development of the paraventricular nucleus of the hypothalamus. J Comp Neurol. 518:2710–2728. PubMed PMC

Sellgren CM, Gracias J, Jungholm O, Perlis RH, Engberg G, Schwieler L, et al. (2019): Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls. Transl Psychiatry. 9:37. PubMed PMC

Nilsson LK, Linderholm KR, Engberg G, Paulson L, Blennow K, Lindstrom LH, et al. (2005): Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr Res. 80:315–322. PubMed

Miller CL, Llenos IC, Dulay JR, Weis S (2006): Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res. 1073-1074:25–37. PubMed

Sathyasaikumar KV, Stachowski EK, Wonodi I, Roberts RC, Rassoulpour A, McMahon RP, et al. (2011): Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull. 37:1147–1156. PubMed PMC

Kindler J, Lim CK, Weickert CS, Boerrigter D, Galletly C, Liu D, et al. (2019): Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Mol Psychiatry. PubMed PMC

Strasser B, Becker K, Fuchs D, Gostner JM (2017): Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions. Neuropharmacology. 112:286–296. PubMed

Ortona E, Pierdominici M, Rider V (2019): Sex Hormones and Gender Differences in Immune Responses. Front Immunol, pp 186. PubMed PMC

Hochgreb-Hagele T, Koo DE, Bronner ME (2015): Znf385C mediates a novel p53-dependent transcriptional switch to control timing of facial bone formation. Dev Biol. 400:23–32. PubMed

Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. (2019): The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47:D1005–D1012. PubMed PMC

Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T, et al. (2017): GeneHancer: Genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017. PubMed PMC

Ziats MN, Rennert OM (2013): Sex-biased gene expression in the developing brain: Implications for autism spectrum disorders. Mol Autism. 4:10. PubMed PMC

Seney ML, Huo Z, Cahill K, French L, Puralewski R, Zhang J, et al. (2018): Opposite molecular signatures of depression in men and women. Biol Psychiatry. 84:18–27. PubMed PMC

Labonté B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, et al. (2017): Sex-specific transcriptional signatures in human depression. Nat Med. 23:1102–1111. PubMed PMC

McCarthy MM (2019): Sex differences in neuroimmunity as an inherent risk factor. Neuropsychopharmacology. 44:38–44. PubMed PMC

Wang K, Baldassano R, Zhang H, Qu HQ, Imielinski M, Kugathasan S, et al. (2010): Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet. 19:2059–2067. PubMed PMC

Byars SG, Stearns SC, Boomsma JJ (2014): Opposite risk patterns for autism and schizophrenia are associated with normal variation in birth size: Phenotypic support for hypothesized diametric gene-dosage effects. Proc Biol Sci. 281:20140604. PubMed PMC

Crespi B, Badcock C (2008): Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci. 31:241–261; discussion 261-320. PubMed

Cross-Disorder Group of the Psychiatric Genomics Consortium (2019): Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 179:1469–1482 e1411. PubMed PMC

Goldstein JM, Hale T, Foster SL, Tobet SA, Handa RJ (2019): Sex differences in major depression and comorbidity of cardiometabolic disorders: impact of prenatal stress and immune exposures. Neuropsychopharmacology. 44:59–70. PubMed PMC

Malamitsi-Puchner A, Tziotis J, Tsonou A, Protonotariou E, Sarandakou A, Creatsas G (2000): Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Investig. 7:309–312. PubMed

Mahoney ER, Dumitrescu L, Moore AM, Cambronero FE, De Jager PL, Koran MEI, et al. (2019): Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. doi: 10.1038/s41380-019-0458-5. PubMed DOI PMC

Frahm KA, Schow MJ, Tobet SA (2012): The vasculature within the paraventricular nucleus of the hypothalamus in mice varies as a function of development, subnuclear location, and GABA signaling. Horm Metab Res. 44:619–624. PubMed

Frahm KA, Handa RJ, Tobet SA (2018): Embryonic exposure to dexamethasone affects nonneuronal cells in the adult paraventricular nucleus of the hypothalamus. J Endocr Soc. 2:140–153. PubMed PMC

Mayne BT, Bianco-Miotto T, Buckberry S, Breen J, Clifton V, Shoubridge C, et al. (2016): Large scale gene expression meta-analysis reveals tissue-specific, sex-biased gene expression in humans. Front Genet. 7:183. PubMed PMC

Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. (2018): Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 50:912–919. PubMed PMC

Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. (2018): Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 50:1112–1121. PubMed PMC

Howard DM, Adams MJ, Shirali M, Clarke TK, Marioni RE, Davies G, et al. (2018): Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. Nat Commun. 9:1470. PubMed PMC

Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, et al. (2017): Landscape of X chromosome inactivation across human tissues. Nature. 550:244–248. PubMed PMC

Shi L, Zhang Z, Su B (2016): Sex biased gene expression profiling of human brains at major developmental stages. Sci Rep. 6:21181. PubMed PMC

Lopes-Ramos CM, Chen CY, Kuijjer ML, Paulson JN, Sonawane AR, Fagny M, et al. (2020): Sex differences in gene expression and regulatory networks across 29 human tissues. Cell Rep. 31:107795. PubMed PMC

Schizophrenia Working Group of the Psychiatric Genomics Consortium, Ripke S, Walters JTR, O'Donovan MC (2020): Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia. medRxiv. doi: 10.1101/2020.09.12.20192922. DOI

Pirastu N, Cordioli M, Nandakumar P, Mignogna G, Abdellaoui A, Hollis B, et al. (2020): Genetic analyses identify widespread sex-differential participation bias. bioRxiv. doi: 10.1101/2020.03.22.001453. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...